COMMUNIQUÉS West-GlobeNewswire

Codexis Reports Second Quarter 2026 Financial Results
11/08/2026
Reports revenue of $14.9 million for the second quarter of 2026, company reiterates full-year financial guidance Shared new advances in RNA therapeutic manufacturing at TIDES US showing that its ECO Synthesis® [...]
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
11/08/2026
First-in-class immune-stimulating antibody conjugate BDC-4182 Phase 1/2 study ongoing, initial clinical data expected to be released with Bolt's 3Q 2026 results Cash balance of $18.1 million as of June 30, 2026 [...]
LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
11/08/2026
Q2 2026 total revenue of $5.5 million from VIZZ product sales and global license agreements Strong patient persistence, with over 60% of patients in our dominant ePharmacy channel purchasing multiple monthly packs since [...]
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited)
11/08/2026
FORT WORTH, TX, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” “Sanara MedTech,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and [...]
Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
11/08/2026
Positive Phase 2 CRDF-004 data presented in an oral session at ASCO support advancement of 30 mg onvansertib plus FOLFIRI/bevacizumab into planned registrational program for first-line RAS-mutated mCRC Following [...]
FocalTherics™ Announces Proposed Public Offering of American Depositary Shares
11/08/2026
FocalTherics™ Announces Proposed Public Offering of American Depositary Shares AUSTIN, Texas and LYON, France, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (NASDAQ: FOCL) (the “Company”), a global leader in robotic [...]
FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026
11/08/2026
FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026 AUSTIN, Texas, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, [...]
Apollomics Announces $10 Million Private Placement Transaction
11/08/2026
FOSTER CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM ) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to [...]
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc., or BBOT (NASDAQ: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway malignancies, today [...]
Aardvark Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
11/08/2026
Assessing unblinded Phase 3 HERO and OLE data for ARD-101 in PWS in the third quarter of 2026 to support an informed determination of next steps Remains in active discussions with the FDA to support resolution of the [...]
Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results
11/08/2026
New data presented at Digestive Disease Week (DDW) demonstrating improvement of fibrosis and inflammation following a single treatment of EP-104GI Strengthened executive team and board to bolster late-stage drug [...]
COSCIENS Biopharma Inc. Reports Q2 2026 Results
11/08/2026
TORONTO, ONTARIO, Aug. 11, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCI.F) (“ COSCIENS ” or the “ Company ”) today reported its financial and operating results for the second quarter ended [...]
The Rehab Podcast Refocuses on Benzodiazepine Tapering, Protracted Withdrawal, and BIND
11/08/2026
The Mental Health News Radio Network program, hosted by Mark Leeds, D.O., is turning toward benzodiazepine-related conditions and deprescribing, and is opening guest booking to clinicians, researchers, and people with [...]
New Horizons Recognized as Best Senior Living in Massachusetts
11/08/2026
Prestigious Award Highlights Excellence in Senior Care and Community Living Marlborough, MA, Aug. 11, 2026 (GLOBE NEWSWIRE) -- New Horizons, a not-for-profit senior living community located in Marlborough, Massachusetts [...]
Medfluence Advisors Named to the 2026 Inc. 5000 List of America's Fastest-Growing Private Companies
11/08/2026
Recognition affirms the disciplined, integrated approach that has guided Medfluence—and the healthcare organizations it serves—since 2020. Greenwood Village, CO, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Medfluence Advisors has [...]
A Race Against Blindness Launches "Right Toyota Spree" Fundraiser
11/08/2026
Innovative partnership with Right Toyota features $150,000 shopping spree and $50,000 cash for a fundraiser to help fund research for inherited retinal diseases GILBERT, Ariz., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Today, A [...]
Bio Usawa and BioVax Partner to Strengthen Kenya’s Biologics Manufacturing Ecosystem
11/08/2026
Partnership will advance local manufacturing of biologic medicines and expand access to innovative treatments for patients in Kenya and across Africa NAIROBI, Kenya, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Bio Usawa Biotech [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
11/08/2026
Company Announcement COPENHAGEN, Denmark; August 11, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 24,592 shares as a consequence of the exercise of employee warrants. The increase is effected [...]
Wandercraft Receives FDA Clearance for Eve, the World’s First Self-Balancing Personal Exoskeleton, for Eligible Wheelchair Users Living with Spinal Cord Injuries at Any Level
11/08/2026
Clearance opens a new category of self-balancing robotics for people living with severe mobility disabilities and advances Eve toward commercial launch within established Medicare reimbursement pathway NEW YORK, Aug. 11 [...]

Pages